Tender Details

Country: Poland
Summary: Delivery of Drug 72 (Drug Programs and Chemotherapy)
PLT Ref No: 92974020
Deadline: 03 Jan 2024
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 726703-2023
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Package No. 1 5-aminolevulinic acid
Package No. 2 Denosumab
Package No. 3 Anakinra
Package No. 4 Docetaxelum
Package No. 5 Risankizumabum
Package No. 6 Darboetin Alfa
Package No. 7 Lamivudinum
Package No. 8 Venetoclaxum
Package No. 9 Melphalanum
Package No. 10 Fluorouracilum
Package No. 11 Busulfanum
Package No. 12 - Bleomycini sulfas
Package No. 13 - Bortezomib
Package No. 14 - Brentuximab vedotin
Package No. 15 - Chlormetine
Package No. 16 - Epoetinum alfa
Package No. 17 - Pixantroni
Package No. 18 - Blinatumomab
Package No. 19 Pomalidomium
Package No. 20 Dacarbazinum
Package No. 21 Trastuzumabum
Pakiet No. 22 Ropeginterferonum alfa 2b
Package No. 23 Tolvaptanum
Package No. 24 Cabozantinibum
Package No. 25 Durvalumabum
Package No. 26 Hydroxycarrbamidum
Package No. 27 Vinorelbinum
Package No. 28 Abemaciclibum
Package No. 29 Tyldrakizumab
Package No. 30 Avatrombopaq
Package No. 31 Bevacizumab
Package No. 32 Luspaterceptum
Package No. 33 Avapritinib
Package No. 34 Eltrombopagum
Package No. 35 Methotrexatum
5-aminolevulinic acid
Denosumab
Anakinra
Docetaxelum
Risankizumabum
Darboetin Alfa
Lamivudinum
Venetoclaxum
Melphalanum
Flu orouracilum
Busulfanum
Bleomycini sulfas
Bortezomib
Brentuximab vedotin
Chlormethine
Epoetin alfa
Pixantrone
Blinatumomab
Pomalidomium
Dacarbazine
Trastuzumab
Ropeginterferon alfa 2b
Tolvaptan
Cabozantinib
Durvalumab
Hydroxycarbamide
Vinorelbine
Abemaciclib
Tyldrakizumab
Avatrombopaq
Bevacizumab
Luspatercept
Awaprytinib
Eltrombopag...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Delivery of Drug 72 (Drug Programs and Chemotherapy) - Poland Tender

The INDEPENDENT PUBLIC CLINICAL HOSPITAL NAMED AFTER A. MIELĘCKI MEDICAL UNIVERSITY OF SILESIA IN KATOWICE, a Government sector organization in Poland, has announced a new tender for Delivery of Drug 72 (Drug Programs and Chemotherapy). This tender is published on PolandTenders under PLT Ref No: 92974020 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-01-03.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.